Anita Verma

Dr. Anita Verma

Nanobiotech Lab, Kirori Mal College, University of Delhi, Delhi-110007

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 January 2017 in Pharmaceutical Research
Verified
Journal Article
Closed access
PDF file
VKVijay Kumar
Vijay Kumar
ALAnkita Leekha
Ankita Leekha
ATAakriti Tyagi
Aakriti Tyagi
AKAnkur Kaul
Ankur Kaul
AMAnil Kumar Mishra
Anil Kumar Mishra
AVAnita Verma
Anita Verma

27 June 2023 in Journal of Materials Chemistry B
Verified
Journal Article
Open access
PDF file
KNKaustubh Naik
Kaustubh Naik
PSPriyanka Singh
Priyanka Singh
MYMonika Yadav
Monika Yadav
SSSaurabh Kr Srivastava
Saurabh Kr Srivastava
STShikha Tripathi
Shikha Tripathi
APAvanish Parmar
Avanish Parmar
Protein-based biomaterials, particularly amyloids, have sparked considerable scientific interest in recent years due to their exceptional mechanical strength, excellent biocompatibility and bioactivity. In this work, we have synthesized a novel amyloid-based composite hydrogel consisting of bovine serum albumin (BSA) and aloe vera (AV) gel to utilize the medicinal properties of the AV gel and circumvent its mechanical frangibility. The synthesized composite hydrogel demonstrated an excellent porous structure, self-fluorescence, non-toxicity, and controlled rheological properties. Moreover, this hydrogel possesses inherent antioxidant and antibacterial properties, which accelerate the rapid healing of wounds. The in vitro wound healing capabilities of the synthesized composite hydrogel were evaluated using 3T3 fibroblast cells. Moreover, the efficacy of the hydrogel in accelerating chronic wound healing via collagen crosslinking was investigated through in vivo experiments using a diabetic mouse skin model. The findings indicate that the composite hydrogel, when applied, promotes wound healing by inducing collagen deposition and upregulating the expression of vascular endothelial growth factor (VEGF) and its receptors. We also demonstrate the feasibility of the 3D printing of the BSA–AV hydrogel, which can be tailored to treat various types of wound. The 3D printed hydrogel exhibits excellent shape fidelity and mechanical properties that can be utilized for personalized treatment and rapid chronic wound healing. Taken together, the BSA–AV hydrogel has great potential as a bio-ink in tissue engineering as a dermal substitute for customizable skin regeneration.

9 September 2016 in Journal of Cancer Research and Clinical Oncology
Verified
Journal Article
Closed access
PDF file
ALAnkita Leekha
Ankita Leekha
BGBahadur S. Gurjar
Bahadur S. Gurjar
ATAakriti Tyagi
Aakriti Tyagi
MRMoshahid Alam Rizvi
Moshahid Alam Rizvi
AVAnita Verma
Anita Verma

1 February 2021 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
SPShweta Pandey
Shweta Pandey
NRNishant Rai
Nishant Rai
AMAsiya Mahtab
Asiya Mahtab
DMDisha Mittal
Disha Mittal
FAFarhan Jalees Ahmad
Farhan Jalees Ahmad
STSushama Talegaonkar
Sushama Talegaonkar

18 July 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
NSNupur Shrivastava
Nupur Shrivastava
APAnkit Parikh
Ankit Parikh
RDRikeshwer Prasad Dewangan
Rikeshwer Prasad Dewangan
LBLargee Biswas
Largee Biswas
AVAnita Verma
Anita Verma
SBSANJULA BABOOTA
SANJULA BABOOTA
The solid self-nanoemulsifying drug delivery system (s-SNEDDS) is a growing platform for the delivery of drugs via oral route. In the present work, tamoxifen (TAM) was loaded in SNEDDS with resveratrol (RES), which is a potent chemotherapeutic, antioxidant, anti-inflammatory and P-gp inhibitor for enhancing bioavailability and to obtain synergistic anti-cancer effect against breast cancer. SNEDDS were developed using capmul MCM as oil, Tween 80 as surfactant and transcutol-HP as co-surfactant and optimized by central composite rotatable design. Neusilin US2 concentration was optimized for adsorption of liquid SNEDDS to prepare s-SNEDDS. The developed formulation was characterized and investigated for various in vitro and cell line comparative studies. Optimized TAM-RES-s-SNEDDS showed spherical droplets of a size less than 200 nm. In all in vitro studies, TAM-RES-s-SNEDDS showed significantly improved (p ˂ 0.05) release and permeation across the dialysis membrane and intestinal lumen. Moreover, TAM-RES-s-SNEDDS possessed significantly greater therapeutic efficacy (p < 0.05) and better internalization on the MCF-7 cell line as compared to the conventional formulation. Additionally, oral bioavailability of TAM from SNEDDS was 1.63 folds significantly higher (p < 0.05) than that of combination suspension and 4.16 folds significantly higher (p < 0.05) than TAM suspension. Thus, findings suggest that TAM- RES-s-SNEDDS can be the future delivery system that potentially delivers both drugs to cancer cells for better treatment.

12 March 2021 in Biomedicines
Verified
Journal Article
Open access
PDF file
NLNisha Lamichhane
Nisha Lamichhane
SSShalini Sharma
Shalini Sharma
PAParul
Parul
AVAnita Verma
Anita Verma
IRIndrajit ROY
Indrajit ROY
Tapas SenTapas Sen
Tapas Sen
Iron oxide nanoparticles (IONPs) have played a pivotal role in the development of nanomedicine owing to their versatile functions at the nanoscale, which facilitates targeted delivery, high contrast imaging, and on-demand therapy. Some biomedical inadequacies of IONPs on their own, such as the poor resolution of IONP-based Magnetic Resonance Imaging (MRI), can be overcome by co-incorporating optical probes onto them, which can be either molecule- or nanoparticulate-based. Optical probe incorporated IONPs, together with two prominent non-ionizing radiation sources (i.e., magnetic field and light), enable a myriad of biomedical applications from early detection to targeted treatment of various diseases. In this context, many research articles are in the public domain on magneto-optical nanoparticles; discussed in detail are fabrication strategies for their application in the biomedical field; however, lacking is a comprehensive review on real-life applications in vivo, their toxicity, and the prospect of bench-to-bedside clinical studies. Therefore, in this review, we focused on selecting such important nanocomposites where IONPs become the magnetic component, conjugated with various types of optical probes; we clearly classified them into class 1 to class 6 categories and present only in vivo studies. In addition, we briefly discuss the potential toxicity of such nanocomposites and their respective challenges for clinical translations.